Fut, nem toboroz1. fázis
A Phase 1b Dose Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors
Key facts
- Where
- Badalona, Barcelona és Madrid, SpanyolországSee the 5 sites
- Phase
- 1. fázis
Where in Spanyolország
- Institut Catala d'OncologiaBadalona, SpanyolországNo longer taking part
- Hospital Clinic de BarcelonaBarcelona, SpanyolországNo longer taking part
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
- Hospital Universitario 12 de OctubreMadrid, SpanyolországNo longer taking part
- Hospital Universitario Ramón y CajalMadrid, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Exelixis Inc.
- Trial code
- EU 2024-516477-73-00
- Record updated
- 2026. szeptember 29.